Department of Neurosurgery, The Johns Hopkins Hospital, Baltimore, MD 21287, USA.
J Neurointerv Surg. 2012 Mar;4(2):116-20. doi: 10.1136/jnis.2011.004911. Epub 2011 May 11.
Aneurysm recurrence is a principle limitation of endovascular coiling procedures, with recurrence rates reported of >30%. The adjunct use of self-expandable stents has revolutionized the treatment of intracranial aneurysms, especially for complex morphologies, wide necks or unfavorable dome to neck ratios. However, further investigation into the durability and outcomes of stent assisted coiling procedures is required.
The records of a prospective single center aneurysm database were retrospectively reviewed, and 90 consecutive patients with paraophthalmic aneurysms who underwent coil embolization were identified, 30 of which included stent placement. Patient demographics, aneurysm characteristics, coil packing density, angiographic results (initial and follow-up) and complications were analyzed.
Complete aneurysm occlusion was obtained on initial angiography in 13/30 (43.3%) stented and 19/60 (31.7%) non-stented patients. At ≤24 months (mean follow-up 12.8±6.2 months for stented and 12.8±6.6 months for non-stented group), aneurysm recurrence occurred in 3/26 (11.5%) stented and 14/39 (35.9%) non-stented patients (p<0.05). At the longest follow-up (mean 14.5±12.5 months for stented and 37.6±35.3 months for non-stented), aneurysm recurrence occurred in 4/26 (15.4%) stented and 17/41 (41.5%) non-stented patients (p<0.03). There was no statistically significant correlation between recurrence and aneurysm size or coiling packing.
Following endovascular coil embolization of paraophthalmic region aneurysms, recurrence rates at 2 years were significantly lower in patients who had stent assisted coiling (11.5%) compared with patients who had coiling procedures without the use of a stent (35.9%). Aneurysm size and coiling packing density did not significantly affect recurrence in our study population.
动脉瘤复发是血管内线圈栓塞术的主要限制,复发率报告>30%。自膨式支架的辅助使用彻底改变了颅内动脉瘤的治疗,特别是对于复杂形态、宽颈或不利的瘤颈比。然而,需要进一步研究支架辅助线圈栓塞术的耐久性和结果。
回顾性分析前瞻性单中心动脉瘤数据库的记录,确定了 90 例接受线圈栓塞治疗的眶周动脉瘤患者,其中 30 例患者接受支架置入。分析患者的人口统计学特征、动脉瘤特征、线圈填塞密度、血管造影结果(初始和随访)和并发症。
在初始血管造影中,30 例支架置入患者中有 13 例(43.3%)和 60 例非支架置入患者中有 19 例(31.7%)获得完全动脉瘤闭塞。在≤24 个月(支架置入组的平均随访时间为 12.8±6.2 个月,非支架置入组为 12.8±6.6 个月),支架置入组有 3 例(11.5%)和非支架置入组有 14 例(35.9%)患者发生动脉瘤复发(p<0.05)。在最长随访时间(支架置入组平均为 14.5±12.5 个月,非支架置入组为 37.6±35.3 个月),支架置入组有 4 例(15.4%)和非支架置入组有 17 例(41.5%)患者发生动脉瘤复发(p<0.03)。复发与动脉瘤大小或线圈填塞密度之间无统计学显著相关性。
在眼眶区域动脉瘤的血管内线圈栓塞后,支架辅助线圈栓塞组的 2 年复发率明显低于未使用支架的线圈栓塞组(11.5%比 35.9%)。在我们的研究人群中,动脉瘤大小和线圈填塞密度对复发无显著影响。